Overview
Validation of ICG to Identify the Urethra During Rectal Surgery
Status:
Terminated
Terminated
Trial end date:
2018-08-01
2018-08-01
Target enrollment:
0
0
Participant gender:
Male
Male
Summary
This is an open-label feasibility study utilising direct instillation of ICG into the urethra during surgery for low rectal cancers. The trial involves a single intervention taking place during the patient's operation. Participants will be included in the study for around 2 months with time either side of the intervention to collect background data.Phase:
Phase 1/Phase 2Accepts Healthy Volunteers?
Accepts Healthy VolunteersDetails
Lead Sponsor:
Oxford University Hospitals NHS TrustCollaborator:
University of Oxford
Criteria
Inclusion Criteria:- Participant is willing and able to give informed consent for participation in the
study.
- Male, aged 18 years or above.
- Undergoing low rectal surgery where the operating field will be close to the urethra
Exclusion Criteria:
- Participant has an allergy to iodine or ICG
- Known liver failure